Register
Journal Updates
eMediNexus Coverage from: 
Shingrix Decreases Shingles Incidence in Blood Ca Patients Post-Transplant
eMediNexus,  10 July 2019
remove_red_eye 545 Views
#Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health #Transplantation

0 Read Comments                

Patients who underwent autologous hematopoietic stem cell transplantation (HSCT) and received the recombinant herpes zoster vaccine (Shingrix) had a lower incidence of the illness compared with HSCT patients receiving placebo, noted a randomized trial.During a median follow-up of 21 months, there was at least one herpes zoster case confirmed in 49 patients who received the vaccine and in 135 patients who received placebo (incidence rate ratio 0.32, 95% CI 0.22-0.44, P
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!